Michael Storek
Company: Sanofi
Job title: Head of Complement Cluster
Seminars:
Panel Discussion: Defining the Therapeutic Windows of Drugs to Ensure Patient Safety Whilst Maintaining Drug Efficacy 9:50 am
Balancing the therapeutic index versus safety in targeting complement Discussing this in the context of disease versus healthy complement inhibition Reviewing the therapeutic window when you target classical, lectin or alternative pathways Discussing pharmacokinetics of targeting complement Specifying inclusion/exclusion criteria put in place specifically due to safety considerations e.g. avoiding comorbidities or infectionsRead more
day: Day One
Complement Industry Leaders’ Chat – 2021/22 in Review & Looking Ahead 8:40 am
This panel will discuss the key breakthroughs that have happened this year, the key challenges that have been overcome and where the biggest excitement remains: How do you perceive the complement drug development space? How has this changed in the past 12 months? What is missing from complement drug discovery and translation into the clinic?…Read more
day: Day One
Chair’s Opening Remarks 8:30 am
day: Day One